Table 1.
Variables | HIV positive n (%) | Non‐HIV n (%) | Total n (%) |
---|---|---|---|
Total | 1020 | 412 | 1432 |
Sex | |||
Male | 405 (40) | 108 (26) | 513 (36) |
Female | 615 (60) | 304 (74) | 919 (64) |
Age (years) | |||
25–45 | 745 (73) | 168 (41) | 913 (64) |
>45–75 | 265 (26) | 243 (59) | 508 (35) |
Not recorded | 10 (1) | 1 (0) | 11 (1) |
Duration on treatment at time of enrolment (months) | |||
>6 months < 12 months | 2 (<1) | 8 (2) | 10 (0.7) |
>12 months‐24 months | 1 (<1) | 54 (13) | 55 (4) |
>24 months | 1009 (99) | 346 (84) | 1355 (95) |
Not recorded | 8 (0.8) | 4 (1) | 12 (0.8) |
Hypertensive | 12 (1) | 352 (85) | 364 (25) |
Diabetic | 0 (0) | 60 (15) | 60 (4) |
Median systolic pressure (IQR) | 122 (114–135) | 137 (125–150) | 127 (117–141) |
Median diastolic pressure (IQR) | 73 (67–80) | 80 (74–88) | 76 (69–84) |
Median HBA1c (IQR) | n/a | 8 (8.0–8.0) | |
CD4 for HIV | |||
≤200 mm3 | 47 (5) | n/a | n/a |
>201 mm3 | 969 (95) | n/a | n/a |
Viral load | |||
≤ 450 copies/ml | 999 (98) | n/a | n/a |
> 451 < 1000 copies/ml | 20 (2) | n/a | n/a |
n/a, not applicable.